Lyell Immunopharma, Inc.2024财年实现净利润-3.43亿美元,同比减少45.96%

市场透视
13 Mar

3月14日,Lyell Immunopharma, Inc.(LYEL.US)公布财报,公告显示公司2024财年净利润为-3.43亿美元,同比减少45.96%;其中营业收入为61000.00美元,同比减少53.08%,每股基本收益为-1.31美元。从资产负债表来看,Lyell Immunopharma, Inc.(LYEL.US)总负债1.08亿美元,其中短期债务7.97百万美元,资产负债比为...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

no data

No relevant data is available

If the download button clicks without skipping, click on the top right menu and select "Open in Browser."